Evidence map›Paper›PMID 39697232›Full record

ArticleFrontiers in oncology2024

DenseIncepS115: a novel network-level fusion framework for Alzheimer's disease prediction using MRI images.

Fatima Rauf, Muhammad Attique Khan, Ghassen Ben Brahim, Wardah Abrar, Areej Alasiry, Mehrez Marzougui, Seob Jeon, Yunyoung Nam

Abstract read
In one paragraph

Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fatima RaufDepartment of Computer Science, HITEC University, Taxila, Pakistan.
Muhammad Attique KhanDepartment of Artificial Intelligence (AI), College of Computer Engineering and Science, Prince Mohammad Bin Fahd University, Al Khobar, Saudi Arabia.
Ghassen Ben BrahimDepartment of Artificial Intelligence (AI), College of Computer Engineering and Science, Prince Mohammad Bin Fahd University, Al Khobar, Saudi Arabia.
Wardah AbrarDepartment of Computer Science, HITEC University, Taxila, Pakistan.
Areej AlasiryCollege of Computer Science, King Khalid University, Abha, Saudi Arabia.
Mehrez MarzouguiCollege of Computer Science, King Khalid University, Abha, Saudi Arabia.
Seob JeonDepartment of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Republic of Korea.
Yunyoung NamICT Convergence Research Centre, Soonchunhyang University, Asan, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the most prevalent disorders relating to neurodegenerative conditions and dementia is Alzheimer's disease (AD). In the age group 65 and older, the prevalence of Alzheimer's disease is increasing. Before symptoms showed up, the disease had grown to a severe stage and resulted in an irreversible brain disorder that is not treatable with medication or other therapies. Therefore, early prediction is essential to slow down AD progression. Computer-aided diagnosis systems can be used as a second opinion by radiologists in their clinics to predict AD using MRI scans. In this work, we proposed a novel deep learning architecture named DenseIncepS115for for AD prediction from MRI scans. The proposed architecture is based on the Inception Module with Self-Attention (InceptionSA) and the Dense Module with Self-Attention (DenseSA). Both modules are fused at the network level using a depth concatenation layer. The proposed architecture hyperparameters are initialized using Bayesian Optimization, which impacts the better learning of the selected datasets. In the testing phase, features are extracted from the depth concatenation layer, which is further optimized using the Catch Fish Optimization (CFO) algorithm and passed to shallow wide neural network classifiers for the final prediction. In addition, the proposed DenseIncepS115 architecture is interpreted through Lime and Gradcam explainable techniques. Two publicly available datasets were employed in the experimental process: Alzheimer's ADNI and Alzheimer's classes MRI. On both datasets, the proposed architecture obtained an accuracy level of 99.5% and 98.5%, respectively. Detailed ablation studies and comparisons with state-of-the-art techniques show that the proposed architecture outperforms.

Indexed as

Alzheimer's diseasedementia stages classificationMRImultiscale inception modulenetwork-level fusionneuroimagingoptimizationshallow neural network

Identifiers

PMID39697232
PMCPMC11653358

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.